With wide application for the cell and gene therapy market, SmartSep™ particularly addresses the increasing need for new solutions to improve the industrial scale required for personalized cell therapies, specifically CAR-T treatments.
Its exceptional cell recovery rates and efficient beads removal process, that prevents bead infusion to the patient considered a major CAR-T industry challenge, positions the company with an excellent solution to streamline production of these two major stages for this rapidly growing multi-million-dollar market.